CAS 201928-39-4

Z-Gly-Ala-Met-AMC

CAS : 201928-39-4

Z-Gly-Ala-Met-AMC is a protease inhibitor that has been shown to inhibit the amyloidogenic processing of β-amyloid and reduce the formation of amyloid plaques in vivo. It also inhibits the degradation of normal proteins by proteases, which leads to cell death. Z-Gly-Ala-Met-AMC is used as a marker for identifying and quantifying proteolytic activity in cells with high levels of proteolytic activity. The drug has been shown to be effective in assays using cell populations and homogenous assays.

Formule : C₂₈H₃₂N₄O₇S

Degré de pureté : Min. 95 Area-%

Couleur et forme : Powder

Masse moléculaire : 568.64 g/mol

Ref: 3D-FG110549